Core Insights - Datasea Inc. has achieved a foundational research breakthrough in ultrasonic-enhanced nanoscale precision control technology, marking a significant advancement in its technical architecture for semiconductor manufacturing applications [1] - The breakthrough integrates ultrasonic enhancement mechanisms with ultra-precision composite manufacturing processes, aiming to improve complexity, stability, and nanoscale accuracy in advanced semiconductor environments [1] - The technology is still in the research and engineering validation stage and has not yet entered commercialization [1] Company Developments - The breakthrough reinforces Datasea's strategic positioning in high-end industrial and advanced manufacturing sectors by leveraging its core acoustic technologies [1] - Management emphasizes that this milestone reflects an architecture-level elevation of their capabilities within high-precision industrial systems [1] - Datasea plans to continue refining its engineering-level architecture through further validation and potential research collaborations [1] Industry Context - As semiconductor nodes shrink and process complexity increases, precision stability, surface uniformity, and nanoscale controllability are becoming critical factors in advanced manufacturing systems [1] - The expansion of ultrasonic precision control into higher-complexity industrial environments demonstrates the scalability of Datasea's acoustic technology architecture beyond health-related and consumer applications [1]

Core Viewpoint - High Liner Foods has launched new Sea Cuisine® Guinness™ Battered Fish Strips and Shrimp, combining the flavors of Guinness with premium seafood to enhance at-home dining experiences [1] Product Overview - The new products include Sea Cuisine Guinness Battered Fish Strips and Shrimp, crafted with responsibly sourced wild-caught Alaska Pollock and shrimp, coated in a batter infused with Guinness flavor [1] - The fish strips contain 12g of protein and the shrimp contains 10g of protein, both are non-alcoholic and designed to deliver restaurant-quality meals at home [1] Market Availability - The products are available in 1,500 Kroger Family of Companies stores and in a 2lb Club Size at Costco across the United States, with plans for further North American expansion [1] Company Background - High Liner Foods is a leading North American processor and marketer of value-added frozen seafood, with a diverse portfolio of brands sold in grocery and club stores [1] - The company is publicly traded on the Toronto Stock Exchange under the symbol HLF [1] Partnership Insights - The collaboration with Guinness aims to showcase how the stout can enhance the flavor of seafood dishes, providing an authentic pub-style experience at home [1]

Core Viewpoint - Carnival Corporation & plc has announced a quarterly cash dividend of $0.15 per share, payable on February 27, 2026, to shareholders of record on February 13, 2026 [1] Group 1: Dividend Announcement - The dividend of $0.15 (U.S.) per share will be paid in U.S. dollars to holders of Carnival Corporation common stock or Carnival plc ADSs [1] - For Carnival plc ordinary shares, the dividend will be payable in sterling unless shareholders elect to receive it in U.S. dollars by February 13, 2026 [1] - The conversion rate for dividends payable in sterling will be based on the exchange rate quoted by Bloomberg at 12 noon London time on February 17, 2026, with the rate being US$1 = 73.72457 pence [1] - Consequently, the dividend payable in sterling will amount to 11.05869 pence per share [1] Group 2: Company Overview - Carnival Corporation & plc is recognized as the largest global cruise company and one of the largest leisure travel companies [1] - The company operates a portfolio of world-class cruise lines, including AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, P&O Cruises, Princess Cruises, and Seabourn [1]

CIMG Inc. Reports Fiscal Year 2025 Financial Results [Accessibility Statement] Skip NavigationHONG KONG, Feb. 18, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today reports its financial results for the fiscal year ended September 30, 2025, as reported in the Company's audited consolidated fin ...

039542.76553.8011.040.235.560.361.160.280.021.18Including552.14553.801.660.758.141.527.601.820.096.11LION MREPML-25- 045368.40370.201.800.5414.461.157.960.980.125.56and380.20389.609.400.257.292.011.830.230.093.26Including381.25385.304.050.4714.504.453.980.520.157.01and40 25-046495.80516.2020.400.689.040.885.011.290.064.11Including496.80505.208.401.4216.661.5010.132.900.078.05Note: Reported length is downhole distance; true width based on model projections is estimated as 85% of downhole length1Copper Equiva ...

Core Insights - A significant decline in retirement confidence is observed among middle-income Americans aged 50 to 85, with one in three (32%) feeling less confident in their retirement plans compared to the previous year [1] - Economic factors such as inflation and uncertainty regarding Social Security and Medicare are major contributors to this decline in confidence [1] Economic Concerns - Inflation is the top concern for middle-income Americans, cited by 27%, followed by fears of outliving savings (23%) and potential cuts to Social Security (18%) [1] - 44% of middle-income Americans report increased anxiety about personal finances compared to a year ago, with pre-retirees showing higher anxiety levels [1] Retirement Planning - Many middle-income Americans are uncertain about their financial plans, with 34% feeling less confident in meeting daily financial obligations [1] - Women and pre-retirees are particularly affected, with 25% of women expressing no confidence in having enough for retirement, nearly double the rate of men [1] Government Program Confidence - Confidence in Social Security and Medicare is waning, with 43% of respondents less confident in Social Security's availability and 47% believing Medicare benefits will be cut [1] - There is a significant knowledge gap regarding long-term care financing, with 49% expecting Medicare to cover all needs despite its limitations [1] Survey Methodology - The survey was conducted by Harris Poll among 500 U.S. respondents aged 50 to 85 with household incomes between $50,000 and $100,000, and less than $1 million in investable assets [1]

Core Insights - NeuroSense Therapeutics announced a statistically significant 65% reduction in the risk of death and a median survival benefit of over 14 months for patients with ALS treated with PrimeC [1] Group 1: Clinical Trial Results - The updated analysis from the PARADIGM Phase 2b clinical trial shows that patients receiving PrimeC had a median survival of 36.3 months compared to 21.4 months for those on placebo, indicating a 70% increase in median survival [1] - The survival benefit was consistent over time, with a log-rank test showing statistical significance (p = 0.0218) [1] - A Cox proportional hazards model indicated that PrimeC treatment was associated with a hazard ratio of 0.35, reflecting a 65% reduction in the risk of death compared to placebo (p = 0.0037) [1] Group 2: Company Overview - NeuroSense is a late-stage clinical biotechnology company focused on developing treatments for neurodegenerative diseases, including ALS, Alzheimer's, and Parkinson's [1] - The company aims to address significant unmet medical needs in neurodegenerative diseases, which currently have limited effective therapeutic options [1] - NeuroSense's strategy involves developing combined therapies targeting multiple pathways associated with these diseases [1] Group 3: Product Information - PrimeC is NeuroSense's lead drug candidate, a novel extended-release oral formulation combining ciprofloxacin and celecoxib, designed to target mechanisms contributing to neuron degeneration and inflammation [1] - The company continues to engage with regulatory authorities to advance PrimeC into pivotal late-stage development, reinforcing the clinical and regulatory foundation for the drug [1]

Core Viewpoint - Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (ZBH) due to concerns over the company's "high confidence" assurances regarding its 2025 revenue targets following a 15% stock decline and reduced revenue guidance [1] Group 1: Investigation Focus - The investigation examines whether Zimmer Biomet's senior management misled investors about the stability of its international business, particularly in emerging markets [1] - The firm is looking into potential violations of federal securities laws related to overly optimistic guidance while concealing operational disruptions [1] Group 2: Recent Developments - On November 5, 2025, Zimmer Biomet reported a year-over-year organic revenue growth of only 5%, significantly missing its forecast and reducing its top-line organic revenue growth forecast to 4% [1] - The company disclosed distributor order cancellations in emerging markets, particularly in the Middle East and Eastern Europe, and acknowledged serious headwinds in Latin America [1] - Following these revelations, CEO Ivan Tornos stated the need for more measured external commentary, which contributed to the 15% drop in stock price on the same day [1] Group 3: Previous Assurances - In an August 7, 2025 earnings call, management expressed "very high" confidence in achieving a year-over-year organic revenue growth forecast of 3.5% to 4.5%, attributing it to emerging markets distributor purchases [1] - These optimistic statements led to a 7% increase in the company's share price on that day [1]

Bank of America Launches Art Consulting Service [Accessibility Statement] Skip NavigationNew Offering Helps Bank of America Private Bank and Merrill Clients Build Art LegaciesNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Bank of America Private Bank today announced the launch of its [Art Consulting service], designed to help Private Bank and Merrill clients navigate the complex and often opaque art market. This new offering provides collectors with trusted, unbiased guidance to help them curate and manage collect ...

Core Insights - LPL Financial and Simplicity Group have formed a strategic relationship to enhance insurance capabilities and support for LPL advisors, effective May 1, 2026 [1] - Simplicity will serve as LPL's preferred Brokerage General Agency, providing advanced technology and comprehensive insurance resources [1] - The partnership aims to improve service experiences for clients seeking protection solutions and offers a broad suite of offerings for high-net-worth clients [1] Company Overview - LPL Financial is a leading wealth management firm supporting over 32,000 financial advisors and approximately 1,200 financial institutions, managing around $2.4 trillion in brokerage and advisory assets for about 8 million Americans [1] - Simplicity Group is recognized as a leading partner for advisors and financial institutions, focusing on wealth accumulation and financial protection products [1] Strategic Benefits - The agreement allows LPL to transition its internal insurance business to Simplicity, creating a unified experience for advisors and clients [1] - This strategic shift enables LPL to reinvest in delivering greater value, flexibility, and improved features for advisors and institutions [1]